CEFTRIAXONE SODIUM FOR INJECTION BP
STERIMAX INC
Quick answers
Is there a shortage of CEFTRIAXONE SODIUM FOR INJECTION BP in Canada?
No. There is no current shortage of CEFTRIAXONE SODIUM FOR INJECTION BP 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ROCEPHIN PWS INJ 0.25GM/VIAL
HOFFMANN-LA ROCHE LIMITED
Other Products
ROCEPHIN PWS 2GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN INJ 10GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS INJ 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
SANDOZ CEFTRIAXONE
SANDOZ CANADA INCORPORATED
DIN
02325594
Strength
250MG
Dosage Form
Powder For Solution
Route
Intravenous Intramuscular
Active Ingredient
CEFTRIAXONE (CEFTRIAXONE SODIUM)
See all CEFTRIAXONE (CEFTRIAXONE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from STERIMAX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02358328
200MG · DIN 02538431
50MG · DIN 02456524
20MG · DIN 00723754
1MG · DIN 02492768
500MG · DIN 02483890
50000UNIT · DIN 02245571
0.05MG · DIN 02413620
10MG · DIN 02413639
10MG · DIN 02413647
7.5MG · DIN 02460645
7.5MG · DIN 02504979